Plasma storage at -80°C does not protect matrix metalloproteinase-9 from degradation

Analytical Biochemistry

Volumn 338, Issue 2, 2005, Pages 294-298

  Rouy, Didier ^a   Ernens, Isabelle ^a   Jeanty, Céline ^a   Wagner, Daniel R ^b  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^b CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

Author keywords

Enzyme; Matrix metalloproteinase; Plasma storage

Indexed keywords

ENZYMES;

ACUTE MYOCARDIAL INFARCTION; CARDIOVASCULAR RISK; ENZYMATIC ACTIVITIES; ENZYME LINKED IMMUNOSORBENT ASSAY; MATRIX METALLOPROTEINASE 9 (MMP 9); MATRIX METALLOPROTEINASE-9; MATRIX METALLOPROTEINASES; STORAGE TEMPERATURES;

METALS;

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ACUTE HEART INFARCTION; ARTICLE; BLOOD STORAGE; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PLASMA; PRIORITY JOURNAL; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 14644426471     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ab.2004.10.052     Document Type: Article

References (26)

1. L.H. Iversen, and O. Thorlacius-Ussing Short-time stability of markers of coagulation and fibrinolysis in frozen plasma Thromb. Res. 81 1996 253 261
2. M. Pieters, J.C. Jerling, and J.W. Weisel Effect of freeze-drying, freezing and frozen storage of blood plasma on fibrin network characteristics Thromb. Res. 107 2002 263 269
3. M.R. Lewis, P.W. Callas, N.S. Jenny, and R.P. Tracy Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples Thromb. Haemost. 86 2001 1495 1500
4. B. Woodhams, O. Girardot, M.J. Blanco, G. Colesse, and Y. Gourmelin Stability of coagulation proteins in frozen plasma Blood Coagul. Fibrinolysis 12 2001 229 236
5. B. Devanapalli, M.A. Bermingham, and D. Mahajan Effect of long-term storage at -80 degrees C on the various lipid parameters in stored plasma samples Clin. Chim. Acta 322 2002 179 181
6. H. Birkedal-Hansen, W.G. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler Matrix metalloproteinases: a review Crit. Rev. Oral Biol. Med. 4 1993 197 250
7. P.E. Van den Steen, B. Dubois, I. Nelissen, P.M. Rudd, R.A. Dwek, and G. Opdenakker Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9) Crit. Rev. Biochem. Mol. Biol. 37 2002 375 536
8. Q.X. Sang, H. Birkedal-Hansen, and H.E. Van Wart Proteolytic and non-proteolytic activation of human neutrophil progelatinase B Biochim. Biophys. Acta 1251 1995 99 108
9. G.S. Makowski, and M.L. Ramsby Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma Anal. Biochem. 322 2003 283 286
10. K. Jung, C. Laube, M. Lein, R. Lichtinghagen, H. Tschesche, D. Schnorr, and S.A. Loening Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood Clin. Chem. 44 1998 1060 1062
11. F. Mannello Effects of blood collection methods on gelatin zymography of matrix metalloproteinases Clin. Chem. 49 2003 339 340
12. K. Jung, M. Lein, C. Laube, and R. Lichtinghagen Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood Clin. Chim. Acta 314 2001 241 244
13. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
14. H. Towbin, T. Staehelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc. Natl. Acad. Sci. USA 76 1979 4350 4354
15. G.S. Makowski, and M.L. Ramsby Calibrating gelatin zymograms with human gelatinase standards Anal. Biochem. 236 1996 353 356
16. A.J. Mackarel, D.C. Cottell, K.J. Russell, M.X. FitzGerald, and C.M. O'Connor Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors Am. J. Respir. Cell Mol. Biol. 20 1999 1209 1219
17. G.I. Goldberg, A. Strongin, I.E. Collier, L.T. Genrich, and B.L. Marmer Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin J. Biol. Chem. 267 1992 4583 4591
18. E.M. Wilson, H.R. Gunasinghe, M.L. Coker, P. Sprunger, D. Lee-Jackson, B. Bozkurt, A. Deswal, D.L. Mann, and F.G. Spinale Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure J. Card. Fail. 8 2002 390 398
19. P. Altieri, C. Brunelli, S. Garibaldi, A. Nicolino, S. Ubaldi, P. Spallarossa, L. Olivotti, P. Rossettin, A. Barsotti, and G. Ghigliotti Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure Eur. J. Clin. Invest. 33 2003 648 656
20. H. Kai, H. Ikeda, H. Yasukawa, M. Kai, Y. Seki, F. Kuwahara, T. Ueno, K. Sugi, and T. Imaizumi Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes J. Am. Coll. Cardiol. 32 1998 368 372
21. Y. Inokubo, H. Hanada, H. Ishizaka, T. Fukushi, T. Kamada, and K. Okumura Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome Am. Heart. J. 141 2001 211 217
22. F.G. Spinale, M.L. Coker, L.J. Heung, B.R. Bond, H.R. Gunasinghe, T. Etoh, A.T. Goldberg, J.L. Zellner, and A.J. Crumbley A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure Circulation 102 2000 1944 1949
23. S. Blankenberg, H.J. Rupprecht, O. Poirier, C. Bickel, M. Smieja, G. Hafner, J. Meyer, F. Cambien, and L. Tiret Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease Circulation 107 2003 1579 1585
24. I.B. Squire, J. Evans, L.L. Ng, I.M. Loftus, and M.M. Thompson Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: Correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction J. Card. Fail. 10 2004 328 333
25. J. Sundstrom, J.C. Evans, E.J. Benjamin, D. Levy, M.G. Larson, D.B. Sawyer, D.A. Siwik, W.S. Colucci, P. Sutherland, P.W. Wilson, and R.S. Vasan Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham heart study Circulation 109 2004 2850 2856
26. Y. Itoh, and H. Nagase Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase J. Biol. Chem. 270 1995 16518 16521